In May 2019, NeoVirTech has been recognized by Pharma Tech Outlook Magazine as Top 10 Drug Discovery & Development Consulting/Services Companies in Europe.
This annual listing highlights 10 companies that are “at the forefront of providing drug discovery and development consulting services and impacting the industry”.
NeoVirTech is very proud of this new achievement, thanks to our cutting-edge antiviral discovery and virus imaging services.
“This achievement is a pride for the team, highlighting all the hard work that has been done so far.” says Franck Gallardo, PhD, CEO of NeoVirTech.
Read the full article in Pharma Tech Outlook Magazine here.
Do not hesitate to contact us for more information on our services: firstname.lastname@example.org